Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium-Reference-Cited by-同舟云学术

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium

Published:2023-05 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bjerner Johan,Bratt Ola,Aas Kirsti,Albertsen Peter C.,Fosså Sophie D.,Kvåle Rune,Lilja Hans,Müller Christoph,Müller Stig,Stensvold Andreas,Thomas Owen,Røe Oluf D.,Vickers Andrew,Walz Jochen,Carlsson Sigrid V.,Oldenburg Jan

Funder

EAU Research Foundation

National Institutes of Health

National Cancer Institute

Västra Götalandsregionen

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group;Vickers;Clin Cancer Res,2010

2. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40–55 and long term risk of metastasis: case-control study;Vickers;BMJ,2013